• About Us
  • Strategy
  • Our Team
  • Portfolio
  • News
  • Contact
  • Building Market-Leading Healthtech Companies

    About Us
    Header Pattern

    Sector Focus

    Medical Devices

    Tools & Diagnostics

    Digital Health

    Tech-Enabled Services

    Our Strategy

    Portfolio

    Leaders in Healthcare Technology Investing

    See All
    Ai Cure StandardLogo retinaCogentix Logo RGB 300x96EndoKeystone 1Med Minder removebg previewNeuro Pace Logo Vert rgb largeStrataVeranexMinerva logo reg 2xSknv

    DEEP EXPERIENCE. SHARED COMMITMENT.

    "We take a private equity approach to a sector that’s traditionally been dominated by venture and early-stage growth firms. We'll work very closely with management to improve the operations of the business, update the product portfolio and revamp the commercial organization. We provide the support and resources our portfolio companies need to succeed.”

    Meet Our Team
    21
    active portfolio companies
    +
    2000
    employees worldwide
    7
    AP-II Investments to Date
    9
    successful exits

    news

    Oct 01, 2024

    Accelmed Announces the Acquisition of Bioventus' Advanced Rehabilitation Business

    Accelmed Partners (“Accelmed”), a private equity firm focused on acquiring and growing commercial-stage HealthTech companies, has announced that they have signed a definitive agreement to acquire Bioness Inc., the Advanced Rehabilitation subsidiary of Bioventus Inc. (Nasdaq: BVS)

    Read More

    Aug 19, 2024

    Minerva Surgical Appoints Darin Hammers as Chief Executive Officer and Member of the Board of Directors

    Minerva Surgical announced the appointment of Darin Hammers as the new President and Chief Executive Officer and Member of the Board.

    Jul 23, 2024

    Bausch + Lomb Acquires Diagnostic Company Trukera Medical

    Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced an affiliate has acquired Trukera Medical, from its private equity owner, Accelmed Partners, and other shareholders. The tuck-in acquisition will help expand Bausch + Lomb’s surgical presence in the United States and contribute to its leading position in dry eye.

    Jul 01, 2024

    Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.

    Asset acquisition expands Merit’s endoscopy portfolio with a minimally invasive solution for patients suffering from chronic gastroesophageal reflux disease (GERD)

    Contact Us

    Partner with Us

    Get in touch